ORCID Profile
0000-0001-8859-7232
Current Organisation
University of Oxford
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: The Royal Society
Date: 05-12-2016
Abstract: Fungal diseases are major threats to the most important crops upon which humanity depends. Were there to be a major epidemic that severely reduced yields, its effects would spread throughout the globalized food system. To explore these ramifications, we use a partial equilibrium economic model of the global food system (IMPACT) to study a hypothetical severe but short-lived epidemic that reduces rice yields in the countries affected by 80%. We modelled a succession of epidemic scenarios of increasing severity, starting with the disease in a single country in southeast Asia and ending with the pathogen present in most of eastern Asia. The epidemic and subsequent crop losses led to substantially increased global rice prices. However, as long as global commodity trade was unrestricted and able to respond fast enough, the effects on in idual calorie consumption were, to a large part, mitigated. Some of the worse effects were projected to be experienced by poor net-rice importing countries in sub-Saharan Africa, which were not affected directly by the disease but suffered because of higher rice prices. We critique the assumptions of our models and explore political economic pressures to restrict trade at times of crisis. We finish by arguing for the importance of ‘stress-testing’ the resilience of the global food system to crop disease and other shocks. This article is part of the themed issue ‘Tackling emerging fungal threats to animal health, food security and ecosystem resilience’.
Publisher: Open Book Publishers
Date: 06-12-2022
DOI: 10.11647/OBP.0321.04
Abstract: Applying evidence builds on the conclusions of the assessment of the evidence. The aim of the chapter is to describe a range of ways of summarising and visualising different types of evidence so that it can be used in various decision-making processes. Evidence can also be presented as part of evidence capture sheets, argument maps, mind maps, theories of change, Bayesian networks or evidence restatements.
Publisher: Open Book Publishers
Date: 06-12-2022
DOI: 10.11647/OBP.0321.12
Abstract: Delivering a revolution in evidence use requires a cultural change across society. For a wide range of groups (practitioners, knowledge brokers, organisations, organisational leaders, policy makers, funders, researchers, journal publishers, the wider conservation community, educators, writers, and journalists), options are described to facilitate a change in practice, and a series of downloadable checklists are provided.
Publisher: Rockefeller University Press
Date: 03-07-2019
DOI: 10.1084/JEM.20182295
Abstract: Vaccination against measles, mumps, and rubella (MMR) and yellow fever (YF) with live attenuated viruses can rarely cause life-threatening disease. Severe illness by MMR vaccines can be caused by inborn errors of type I and/or III interferon (IFN) immunity (mutations in IFNAR2, STAT1, or STAT2). Adverse reactions to the YF vaccine have remained unexplained. We report two otherwise healthy patients, a 9-yr-old boy in Iran with severe measles vaccine disease at 1 yr and a 14-yr-old girl in Brazil with viscerotropic disease caused by the YF vaccine at 12 yr. The Iranian patient is homozygous and the Brazilian patient compound heterozygous for loss-of-function IFNAR1 variations. Patient-derived fibroblasts are susceptible to viruses, including the YF and measles virus vaccine strains, in the absence or presence of exogenous type I IFN. The patients’ fibroblast phenotypes are rescued with WT IFNAR1. Autosomal recessive, complete IFNAR1 deficiency can result in life-threatening complications of vaccination with live attenuated measles and YF viruses in previously healthy in iduals.
Publisher: American Association for the Advancement of Science (AAAS)
Date: 15-09-2023
Publisher: Springer Science and Business Media LLC
Date: 17-04-2020
Publisher: Springer Science and Business Media LLC
Date: 21-01-2021
Location: United Kingdom of Great Britain and Northern Ireland
No related grants have been discovered for Hugh Charles Jonathan Godfray.